摘要
目的:了解卡马西平对精神分裂症患者攻击性行为的疗效。方法:对21例有攻击性行为的住院精神分裂症患者在原有抗精神病药物治疗的基础上合并用卡马西平进行为期6周的治疗,在治疗前及治疗后第6周用简明精神病评定量表(BPRS)、外显攻击行为量表修订版(MOAS)进行评定。结果:治疗前后BPRS各因子分差异无显著性。但治疗后MOAS评分显著降低。结论:卡马西平辅助治疗精神分裂症的攻击性行为安全有效。
Objective：To observe the efficacy of of carbamazepine in the treatment of aggression in schizophrenic patients. Methods ：Twentyone cases of schizophrenic patients show aggressive symptoms were treated with carbamazepine and antipsychotic drugs for 6 weeks. BPRS and MOAS were used to evaluated the patients both in the pre - treatment and in the six week post - treat- ment. Results： There are no significant difference in BPRS score, MOAS score are significantly reduced after treatment. Conclusions： Carbamazepine assisted for the treatment of aggression in schizophrenic patients are effective and safety.
出处
《中国民康医学》
2008年第5期423-423,425,共2页
Medical Journal of Chinese People’s Health
关键词
精神分裂症
攻击行为
卡马西平
Schizophrenia
Aggressive behavior
Carbamazepine
